These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17445114

  • 21. Topiramate for migraine prophylaxis: a reappraisal of the therapeutic premise.
    Gupta VK.
    J Child Neurol; 2007 Jan; 22(1):123-4. PubMed ID: 17608321
    [No Abstract] [Full Text] [Related]

  • 22. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

  • 23. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [Abstract] [Full Text] [Related]

  • 24. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 25. Topiramate: a case series study in migraine prophylaxis.
    Young WB, Hopkins MM, Shechter AL, Silberstein SD.
    Cephalalgia; 2002 Oct; 22(8):659-63. PubMed ID: 12383061
    [Abstract] [Full Text] [Related]

  • 26. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
    Pascual J, Sánchez del Rio M, Mateos V, Láinez JM, Hernández-Gallego J, Leira R, Jiménez MD.
    Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
    [Abstract] [Full Text] [Related]

  • 27. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P, Singh S, Goyal V, Shukla G, Behari M.
    Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
    [Abstract] [Full Text] [Related]

  • 28. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 29. [Topiramate in migraine prophylaxis].
    Andrés-Láinez JM.
    Rev Neurol; 2005 Aug; 43(5):257-8. PubMed ID: 17080575
    [No Abstract] [Full Text] [Related]

  • 30. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
    Luo N, Di W, Zhang A, Wang Y, Ding M, Qi W, Zhu Y, Massing MW, Fang Y.
    Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
    [Abstract] [Full Text] [Related]

  • 37. Topiramate in the prevention of pediatric migraine: literature review.
    Ferraro D, Di Trapani G.
    J Headache Pain; 2008 Jun; 9(3):147-50. PubMed ID: 18385933
    [Abstract] [Full Text] [Related]

  • 38. Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
    Schoenen J, Reuter U, Diener HC, Pfeil J, Schwalen S, Schäuble B, van Oene J.
    Cephalalgia; 2010 Nov; 30(11):1290-5. PubMed ID: 20959424
    [Abstract] [Full Text] [Related]

  • 39. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Nov; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 40. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate.
    Pascual J, El Berdei Y, Gómez-Sánchez JC.
    J Headache Pain; 2007 Apr; 8(2):90-3. PubMed ID: 17221343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.